Linkage studies in multiple sclerosis (MS) identified several susceptibility loci. One of these regions includes chromosome 17q11 where a meta-analysis of data from three genome scans suggested linkage. This region encodes a cluster of genes for b-chemokines or CC chemokine ligands (CCLs), which may be involved in the development of MS lesions. Here we aimed to test if CCL alleles and haplotypes are associated with MS. Using methods of linkage and association, we observed deviations from the expected 50% transmission of haplotypes from unaffected parents to their affected children at CCL2, CCL11 -CCL8-CCL13 and CCL3 within the investigated 1.85 MB chromosomal segment. Analyses of the linkage disequilibrium map support that variants with possible relevance to MS can be located within these subregions. Identification of MS associated CCL variants may have direct clinical significance, as it can lead to the design of small competitive antagonists of these molecules with beneficial effects in the treatment of patients with early and active disease. Keywords: multiple sclerosis; susceptibility; b-chemokines; SNP; haplotype
Introduction
Multiple sclerosis (MS) is a complex trait disorder of unknown etiology. Its phenotypic presentations represent a spectrum with characteristics of autoimmunity and neurodegeneration. 1 -4 The involvement of autoimmunity is supported by epidemiological, clinical and pathological studies. 4 -6 A survey of genome-wide scans reveals that 65%
of the positive non-HLA linkage data map into 18 overlapping clusters of MS and other autoimmune diseases. 3 The risk of this nonspecific autoimmunity is estimated to be l s ¼ 1.65, 7 -8 and involves a complex mechanism with chemokines playing an important role in it. 9 The main function of chemokines and their receptors is to attract immune cells to the site of inflammation. In addition, these small molecules are involved in T-cell differentiation, apoptosis, cell cycle regulation, angiogenesis, metastatic processes and in the generation of soluble inflammatory products such as free radicals, nitric oxide, cytokines and matrix metalloproteases. 9 In humans, approximately 50 chemokine genes have been described, which are divided into four subfamilies based on the characteristic patterns of cysteine residues close to the Nterminal end of molecules. In the CC chemokine ligand family (CCL) (also known as b-chemokines or small cytokine group A -(SCYA)), the two cysteines are adjacent to each other, while in the CXC and CX 3 C chemokine families the two cysteines are separated by one or three amino acids, respectively. In the XC family, only one cysteine is present. 10 Chemokine receptors bind multiple chemokines. Currently, 10 CC chemokine receptors (CCRs), six CXCRs, one CX 3 CR1 and one XCR1 are known. In linkage studies, several MS susceptibility loci have been identified. 8,12 -16 A meta-analysis of three MS genome scans detected the highest score of nonparametric linkage (NPL) ¼ 2.58 at 17q11. 17 While numerous candidate genes are located in this region (eg NOS2A, OMG, NF1), a 1.85 MB segment at 17q11.2 -q12 encodes a cluster of evolutionarily closely related b-chemokines including CCL2, CCL7, CCL11, CCL8, CCL13, CCL1, CCL5, CCL16, CCL14, CCL23, CCL18, CCL3 and CCL4, respectively. Recently, two quantitative trait loci (QTL), eae6 and eae7, were investigated by classic marker-specific linkage and interval mapping in a murine experimental allergic encephalomyelitis (EAE) model. Eae 6 and eae7 mapped to a region of mouse chromosome 11 syntenic to human chromosome 17q11. Eae 6 and eae7 were implicated in the severity and duration of the clinical presentation of EAE. However, eae7 also conferred susceptibility to a monophasic remitting/non-relapsing (MRNR) form of the disease. 18 Sequencing of cDNA for all 11 b-chemokines and NOS2 encoded within eae7 only revealed variations in Scya1, Scya2 and Scya12 (corresponding to the human CCL1, CCL2 and CCL12 genes, respectively). A striking divergence in these Scya1, Scya2 and Scya12 variations was noted when the cDNA molecules of EAE-resistant (eg Balb/ cJ and B10.S/DvTe) and EAE-susceptible strains (eg SJL/J) were compared. As multiple nonsynonymous sequence polymorphisms within Scya1 (TCA-3), Scya2 (MCP-1) and Scya12 (MCP-5) are now established candidates for eae7
(a QTL for the severity and duration, and a susceptibility locus for the MRNR subtype of EAE), we postulate that b-chemokine variants may also confer susceptibility to MS. Table 1) . Separated data sets were received from various sources at various times and genotyped accordingly. The diagnosis of MS for patients whose DNA specimens were obtained from existing collections (MSDB, CMSCG) was made by the Poser criteria. 19 Patients whose specimens were prospectively collected for this study were diagnosed using the McDonald's criteria. 20 The diagnosis of primary-progressive (PP)-MS was established if sustained progression of disability was observed for at least 1 year in the absence of relapses. 21 If one or more relapses occurred superimposed on a progressive course from onset, the disease was classified as progressive-relapsing (PR)-MS.
Genotyping
For genotyping, we contracted ACGT Inc. (Northbrook, IL, USA), a biotech company using the 5 0 Nuclease (or TaqMan) assay for allelic discrimination of single nucleotide polymorphisms (SNPs) with high sensitivity and specificity on an ABI7900HT Instrument (ABI PE Inc., Foster City, CA, USA). PCR amplification of the template DNA sequence was performed with unlabeled forward and reverse primers in the presence of a specifically designed TaqMan probe having a nonfluorescent quencher plus a minor groove binder attached to the 3 0 end, and a reporter 
Single nucleotide polymorphisms
SNPs were identified in the NCBI database (http:// www.ncbi.nlm.nih.gov/SNP). A total of 31 assays were successfully developed and validated. All SNPs were genotyped in three data sets (DS101 -105, DS106 -108, DS109 -112). In DS113 -114 and DS115, data from only 27 assays were obtained, as assays of CCL2B, CCL7N, CCL11X and CCL15M were not included. Table 2 shows the list of genes and SNPs assayed, the location of markers and intermarker distances, and the heterozygosity and the minor allele frequency of SNPs calculated from data of unaffected parents in DS101 -115. Heterozygosity was calculated by using the Pedigree Statistics in MERLIN (Multipoint Engine for Rapid Likelihood Inference, http://www.sph.umich.edu/csg/abecasis/Merlin/). 22 
Analysis
Files Genotyping errors and Mendelian inconsistencies were screened by Pedcheck, and manually corrected based on The table shows the experimental designation of SNPs in b-chemokine genes using the current nomenclature (CCL2, CCL7, etc) and alternative names (MCP-1, MCP-2, etc), and the NCBI Rs numbers, contig positions, intermarker distances, heterozygosity and minor allele frequency of SNPs. SNPs within a gene are indicated with a letter attached to the gene name (eg CCL2B and CCL2X). In this analysis, we only included nonsynonymous, untranslated region and intronic SNPs within CCL genes, but we did not include SNPs between these genes. We intended to include at least two Markers showing allelic associations with multiple sclerosis Analysis of data was carried out separately in each data set, and then in the combined DS101 -115 set. As all data sets contain North-American families with European background and with similar allele frequency distributions, we present here the results from the combined DS101 -115 families ( Table 3 ). The analysis reveals transmission distortion for SNPs CCL2B, CCL11B, CCL5A, CCL18B, CCL18X and CCL3B ( Table 3 ). Considering that 94% of the DS101 -115 families include patients with RR/SP-MS, it is not surprising to detect similar trends of findings in the unstratified and the RR/SP-MS data sets. Although the PP-MS group is small, allelic associations are significant at CCL18B and CCL18X. However, all the significant findings are modest and disappear after using the conservative Bonferroni correction for multiple comparisons.
Haplotypes associated with multiple sclerosis Although no SNP listed in Table 3 has direct relevance to MS, they may define disease-associated haplotypes. We used the TRANSMIT program to evaluate haplotype transmissions (Table 4a and b). A total of 27 two-marker haplotypes generated in a pairwise manner from the list in Table 2 (but skipping subregions with a gap 430 kb) and five threemarker haplotypes in the subregions of two-marker haplotype associations were tested by TRANSMIT. We detected significant P-values for several two-marker haplotypes including CCL2bx, CCL11b -CCL8x, CCL8y-CCL13a, CCL13ab and CCL15om in both DS101 -115 and the RR/ SP-MS groups and for CCL3ba in the RR/SP-MS group. Only one three-marker haplotype, CCL15omn, showed significant distortion in the two groups. However, the number of transmissions and the variance of observed and expected 
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T Vyshkina et al transmissions (o2.5) of the CCL15om and CCL15omn haplotypes are too low to make reliable conclusion. 28 As indicated in Table 4a and b, removal of the PP-MS families from DS101 -115 did not markedly change the outcome of the analyses, and the PP-MS subgroup alone was too small to define reliably a pattern of phenotype-specific associations. Table 5 shows the distribution of the MS-associated haplotypes in correlation with the distribution of intermarker LD in the chr17q11.2 -q12 region. Pairwise distributions of D 0 values indicate that strong LD extends from CCL2B to CCL11B, then it drops significantly and there is no LD between CCL2A and the CCL13A markers. The D 0 values generally correlate with the intermarker distances, and the highest D 0 values (0.7 -1.0) can be observed up to 20 kb. As haplotypes of CCL2bx, CCL13ab, CCL15omn and CCL3ba are defined by markers in strong LD with each other, further investigation of these haplotypes may reveal disease relevant mutations. The varying strength and discontinuous nature of LD observed at CCL11b -CCL8x and CCL8y -CCL13a suggest that more than one haplotype may carry disease relevant variants and fine mapping is necessary in this subregion.
Summary of findings
These analyses suggest that variants of CCL genes are associated with MS. Four subregions of haplotypic associations are detected within the 1.85 MB CCL coding region. We note that candidate genes showing association with all MS phenotypes overlap with those detected in the RR/SP subgroup. The inclusion of PP-MS in the combined analyses did not noticeably modify the outcome, and as a subgroup alone, did not have enough power to draw conclusions regarding differential associations.
Discussion
Linkage studies have defined a number of susceptibility loci in MS. These loci, however, still encompass 2 -20 cM chromosomal segments encoding large numbers of genes. Comparing allele sharing as a method of linkage and TDT as a method of association, Risch and Merikangas 25 demonstrated that TDT is more powerful in detecting genes of modest effect in complex disorders. Subsequently, TDT and related methods assisted in identifying a significant number of candidate genes and alleles within regions of linkage in complex diseases. 31 Based on these considerations, we genotyped and analyzed SNPs within candidate genes located on chromosome 17q11, a previously defined susceptibility locus of MS. 17 Although none of the marker alleles showed direct association with MS after adjusting for multiple comparisons, diseasecausing mutations are likely to be within or near haplotypes located in genes of CCL2 and CCL3 and in the subregion encompassing CCL11 -CCL13 (Table 3 -5) . Because of the low number of transmitted haplotypes, the CCL15 gene region remains to be further investigated. The D 0 values summarized in Table 5 indicate that LD extends up to 20 kb between paired markers in this region. The D 0 value estimates are compatible with those obtained by simulation and experimental assessment of haplotype blocks in several chromosomal regions of Caucasians. 32 The LD map (Table 5) facilitates the design of a highdensity SNP mapping of disease relevant mutations in or close to the identified haplotypes.
Our results are supported by functional observations. CCL5 (RANTES) and CCL3 (MIP-1a) are likely to be involved in the recruitment of mononuclear cells (MNCs) into the central nervous system (CNS) and in the The expression of CCL2 can be induced in various cell types, including glial cells in the CNS. 9 Consistent with the above observations concerning CCL2 and CCL3 in MS, our SNP haplotype analyses revealed that variants within these genes may be associated with the disease.
In conclusion, this study reveals that haplotypes within genes of CCL2, CCL11 -CCL8 -CCL13 and CCL3 are associated with MS. Further investigation of these haplotypes with dense SNP markers in families and in casecontrol cohorts of various ethnic origins will help to determine the variants conferring the highest risks to the development of the disease. If CCL variants produced by activated residential immune cells play an important role in the recruitment, retention and further activation of peripheral immune cells in the CNS, then genetically engineered small molecules with chemokine receptor antagonist properties may beneficially influence the natural history of the disease with autoimmune features and overt inflammatory activity. b-Chemokine haplotypes in MS T Vyshkina et al
